Review
New agents labelled with technetium 99m for myocardial perfusion imaging
Affiliations
- PMID: 1386280
Item in Clipboard
Review
New agents labelled with technetium 99m for myocardial perfusion imaging
Can Assoc Radiol J.
1992 Aug.
Abstract
New agents labelled with technetium 99m (99mTc) are now available for myocardial perfusion imaging. In this article the author reviews the biologic characteristics, the imaging protocols and the clinical usefulness of thallous chloride Tl 201, 99mTc-sestamibi and 99mTc-teboroxime (not yet available in Canada), as well as their complementary roles in the detection of coronary artery disease.
Similar articles
-
Advances in myocardial perfusion imaging: 99mTc-teboroxime.J Nucl Biol Med (1991). 1992 Apr-Jun;36(2 Suppl):22-8. J Nucl Biol Med (1991). 1992. PMID: 1450239 Review. No abstract available.
-
Physiological basis of myocardial perfusion imaging with the technetium 99m agents.Semin Nucl Med. 1991 Jul;21(3):173-81. doi: 10.1016/s0001-2998(05)80038-8. Semin Nucl Med. 1991. PMID: 1835136 Review.
-
Technetium-labeled myocardial perfusion agents.Cardiol Clin. 1994 May;12(2):187-98. Cardiol Clin. 1994. PMID: 8033172 Review.
-
Experimental studies of the physiologic properties of technetium-99m agents: myocardial transport of perfusion imaging agents.Am J Cardiol. 1990 Oct 16;66(13):9E-15E. doi: 10.1016/0002-9149(90)90606-2. Am J Cardiol. 1990. PMID: 2145753 Review.
-
The new 99mTc myocardial perfusion imaging agents: 99mTc-sestamibi and 99mTc-teboroxime.Circulation. 1991 Sep;84(3 Suppl):I7-21. Circulation. 1991. PMID: 1832100 Review.